This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) slipped 5.65% to $9.68 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 1.34% to 48,704.01 and the NASDAQ Composite Index  falling 0.25% to 23,593.86.
Corbus Pharmaceuticals Holdings Inc. closed 52.92% below its 52-week high of $20.56, which the company reached on October 20th.
The stock underperformed when compared to some of its competitors Thursday, as Vanda Pharmaceuticals Inc. (VNDA) fell 2.22% to $6.60, Fortress Biotech Inc. (FBIO) remained unchanged, and Viking Therapeutics Inc. (VKTX) fell 0.85% to $37.21.
Trading volume (5.0 M) eclipsed its 50-day average volume of 518,842.
Data source: Dow Jones Market Data, FactSet. Data compiled December 11, 2025.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-11-25 1723ET

CRBP

<p>Corbus Pharmaceuticals Holdings Inc. (CRBP) shares fell 5.65% to $9.68 on Thursday, underperforming compared to some competitors. The stock is 52.92% below its 52-week high of $20.56. Trading volume was significantly higher than the 50-day average. The Dow Jones rose 1.34%, while the NASDAQ fell 0.25% during the session.</p>

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors